News & ViewsNewslettersContactBecome a Research Patient
DHRHealth Institute for Research and Development

Clinical Trial

A Phase 3, Randomized, Multicenter, Open-Label, Parallel-Group Clinical Study Comparing the Safety and Efficacy of MYL-1601D with NovoLog in Type 1 Diabetes Mellitus Patients (Protocol MYL-1601D-3001)

Study Status:

Closed for enrollment

Please contact us for more information or to learn if you are eligible to participate.

Study Purpose:

A study for patients with Type 1 Diabetes Mellitus that compares the safety and efficacy of MYL-1601D with NovoLog®


Principal Investigator
Marcel B. Twahirwa, MD
Mylan GmbH/Switzerland
Type of Trial
© 2024 DHR Health Institute for Research & Development | All Rights Reserved | Terms & Conditions | Site By: KangoMedia
chevron-down linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram